BiotechTube
Home/Viriom/Robert Redfield, MD
RR

Robert Redfield, MD

Director

Viriom

Therapeutic Areas

HIV/AIDSViral HepatitisRespiratory Viral InfectionsOncology

Viriom Pipeline

DrugIndicationPhase
Elpida® (elsulfavirine) Daily OralHIV-1 InfectionApproved
Elpida® (elsulfavirine) Weekly OralHIV-1 Treatment & Prophylaxis (PrEP/PEP)Phase 2
Agape® FDCHIV-1 InfectionApproved
Depulfavirine Injectable (DPV)HIV-1 InfectionApproved
Elsulfavirine FDCs (w/ NRTI/INSTI)HIV-1 InfectionBioequivalence
VM3500 LA InjectableHIV-1 InfectionPre-clinical
FavipiravirSARS-CoV-2 InfectionBioequivalence

Leadership Team at Viriom

NS
Nikolay Savchuk, PhD
Executive Chairman of the Board
AL
Augustine Lawlor
Director
EW
Eddie Wang Rodriguez, JD
General Counsel
HL
Haishan Li, MD, PhD
Principal Scientist
BR
Boris Rogovoy, PhD
Sr. Director Discovery
View full Viriom profile